1                       There were no cases of radiation pneumonitis.

2 s were chosen based on the estimated risk of radiation pneumonitis.

3  histopathological change that occurs during radiation pneumonitis.

4 ly, there are no biomarkers that can predict radiation pneumonitis.

5 , such as in the use of CT or PET to predict radiation pneumonitis.

6  patient included transient hypoxemia (19%), radiation pneumonitis (11%), and fatigue (4%).

7  the once-daily group; p=0.85) and grade 3-4 radiation pneumonitis (4 [3%] of 254 vs 4 [2%] of 246; p

8       We have also developed a mitigator for radiation pneumonitis and fibrosis that can be started a

9 ic infections, diffuse pulmonary malignancy, radiation pneumonitis, and oxygen toxicity.

10  and gastrointestinal ulcers, cholecystitis, radiation pneumonitis, and radioembolization-induced liv

11  initially thought to have died from grade 5 radiation pneumonitis during the study; however, this ad

12 ized two well-characterized murine models of radiation pneumonitis/fibrosis to compare and contrast d

13                          Early prediction of radiation pneumonitis in time to initiate mitigation wil

14                                              Radiation pneumonitis is reported in 5% to 15% of lung c

15                             Although grade 2 radiation pneumonitis occurred in five patients, grade 3

16 eumonitis occurred in five patients, grade 3 radiation pneumonitis occurred in only two.

17 oint was the incidence of grade 3 or greater radiation pneumonitis (RP).

18  and/or radiographic changes consistent with radiation pneumonitis (t1/2 felt to 19% +/- 6% of baseli

19 d according to patients' stratified risk for radiation pneumonitis with total RT doses ranging from 5